Figures 10(i)–10(k) and 10(m) reveal a strong association between TP53/IDH1 mutation and 8 PR-DE-ERSGs/risk score, suggesting cooperative roles of TP53/IDH1 mutation and ERS in glioma. The gene discussed is TP53; the disease is central nervous system cancer.